Point mutations in KEL exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the kell blood group system

Vox Sanguinis

Volumn 81, Issue 4, 2001, Pages 259-263

  Lee, Soohee ^a   Reid, M E ^a   Redman, C M ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

Genotyping; Kell antigens; Molecular basis; Point mutations

Indexed keywords

BLOOD GROUP ANTIGEN; ANTIGEN;

AMINO ACID SUBSTITUTION; ARTICLE; BLOOD GROUP; BLOOD GROUP KELL SYSTEM; DNA SEQUENCE; GENE MUTATION; GENOTYPE; HUMAN; INCIDENCE; PHENOTYPE; POINT MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; EXON; GENE FREQUENCY; GENETICS; IMMUNOLOGY; NUCLEOTIDE SEQUENCE;

ANTIGENS; BASE SEQUENCE; DNA MUTATIONAL ANALYSIS; EXONS; GENE FREQUENCY; GENOTYPE; HUMANS; KELL BLOOD-GROUP SYSTEM; PHENOTYPE; POINT MUTATION;

EID: 0035524651     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.2001.00119.x     Document Type: Article

References (23)

1. Lee S, Russo D, Redman C: Functional and structural aspects of the Kell blood group system. Transfus Med Rev 2000; 14:93-103
2. Lee S, Russo D, Redman CM: The Kell blood group system: Kell and XK membrane proteins. Semin Hematol 2000; 37:113-121
3. Ho M, Chelly J, Carter N, Danek A, Crocker P, Monaco AP: Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994; 77:869-880
4. Lee S: Molecular basis of Kell blood group phenotypes. Vox Sang 1997; 73:1-11
5. Daniels GL, Petty AC, Reid M, Moulds M, Devenish A, Halil O: Demonstration by the monoclonal antibody-specific immobilization of erythrocyte antigens assay that a new red cell antigen belongs to the Kell blood group system. Transfusion 1994; 34:818-820
6. Jongerius JM, Daniels GL, Overbeeke MAM, Petty AC, Reid M, Oyen R, Rijksen H, Van Leeuwen EF: A new low-incidence antigen in the Kell blood group system: VLAN (Kel25). Vox Sang 1996; 71:43-47
7. Lee S, Wu X, Reid M, Zelinski T, Redman C: Molecular basis of the Kell (KI) phenotype. Blood 1995; 85:912-916
8. Lee S, Naime D, Reid ME, Redman CM: Molecular basis for the high-incidence antigens of the Kell blood group system. Transfusion 1997; 37:1117-1122
9. Marsh WL, Jensen L, Oyen R, Stroup M, Gellerman M, McMahon FJ, Tsitsera H: Anti-K13 and the K:-13 phenotype: a blood-group variant related to the Kell system. Vox Sang 1974; 26:34-40
10. Bertelson CJ, Pogo AO, Chaudhuri A, Marsh WL, Redman CM, Banerjee D, Symmans WA, Simon T, Frey D, Kunkel LM: Localization of the McLeod locus (XK) within Xp21 by deletion analysis. Am J Hum Genet 1988; 42:703-711
11. Ho MF, Chalmer RM, Davis MB, Harding AE, Monaco AP: A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann Neurol 1996; 39:672-675
12. Hanaoka N, Yoshida K, Nakamura A, Furihata K, Seo T, Tani Y, Takahashi J, Ikeda S, Hanyu N: A novel frameshift mutation in the McLeod syndrome gene in a Japanese family. J Neurol Sci 1999; 165:6-9
13. Ueyama H, Kumamoto T, Nagao S, Masuda T, Sugihara R, Fujimoto S, Tsuda T: A novel mutation of the McLeod syndrome gene in a Japanese family. J Neurol Sci 2000; 176:151-154
14. Jung HH, Hergersberg M, Kneifel S, Alkadhi H, Schiess R, Weigell-Weber M, Daniels G, Kollias S, Hess K: McLeod syndrome: a novel mutation, predominant psychiatric manifestations, and distinct striatal imaging findings. Ann Neurol 2001; 49:384-392
15. Yu LC, Twu YC, Chang CY, Lin M: Molecular basis of the Kell null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens. J Biol Chem 2000; 276:10247-10252
16. Lee S, Russo DC, Reiner AP, Lee JH, Sy MY, Telen MJ, Judd WJ, Simon P, Rodrigues MJ, Chabert T, Poole J, Jovanovic-Srzentic S, Levene C, Yahalom V, Redman CM: Molecular defects underlying the Kell null phenotype. J Biol Chem 2001; 276:27281-27289
17. Khamlichi S, Bailly P, Blanchard D, Goossens D, Cartron JP, Bertrand O: Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem 1995; 228:931-934
18. Russo D, Redman C, Lee S: Association of XK and Kell blood group proteins. J Biol Chem 1998; 273:13950-13956
19. Yazdanbakhsh K, Oyen R, Yu Q, Lee S, Antoniou M, Chaudhuri A, Reid ME: High-level, stable expression of blood group antigens in a heterologous system. Am J Hematol 2000; 63:114-124
20. Yazdanbakhsh K, Lee S, Yu Q, Reid ME: Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999; 94:310-318
21. Lee S, Lin M, Mele A, Cao Y, Farmar J, Russo D, Redman C: Proteolytic processing of big endothelin-3 by the Kell blood group protein. Blood 1999; 94:1440-1450
22. Turner AJ, Tanzawa K: Mammalian membrane metallopeptidases: NEP, ECE, KELL, PEX. FASEB J 1997; 11:355-364
23. Turner AJ, Brown CD, Carson JA, Barnes K: The neprilysin family in health and disease. Adv Exp Med Biol 2000; 477:229-240